Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ACHC
ACHC logo

ACHC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Acadia Healthcare Company Inc (ACHC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
24.870
1 Day change
5.83%
52 Week Range
30.200
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Acadia Healthcare Company Inc (ACHC) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows strong upward momentum, positive analyst sentiment, and technical indicators supporting a bullish trend. Despite hedge fund selling, the lack of negative news and the company's operational improvements make it an attractive long-term investment.

Technical Analysis

The technical indicators are bullish: MACD is positively expanding above 0, RSI is neutral at 53.178, and moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level of 24.755, with resistance levels at 25.786 and 26.424.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
8

Positive Catalysts

  • Analysts have upgraded the stock with higher price targets, citing operational improvements, enhanced earnings visibility, and better management execution.

  • The stock has shown strong price momentum, with a 5.83% gain in the regular market session.

  • Technical indicators support a bullish trend.

Neutral/Negative Catalysts

  • Hedge funds are selling the stock, with a significant increase in selling activity (194.77% over the last quarter).

  • No recent news or congress trading data to provide additional sentiment insights.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish on ACHC. Recent upgrades include Jefferies upgrading to Buy with a price target of $30, Raymond James upgrading to Strong Buy with a target of $39, and RBC Capital raising the price target to $31. Analysts highlight operational improvements, higher EBITDA estimates, and better management execution as key drivers for the upgrades.

Wall Street analysts forecast ACHC stock price to fall
11 Analyst Rating
Wall Street analysts forecast ACHC stock price to fall
5 Buy
5 Hold
1 Sell
Moderate Buy
Current: 23.500
sliders
Low
13
Averages
18.1
High
25
Current: 23.500
sliders
Low
13
Averages
18.1
High
25
Jefferies
Brian Tanquilut
Hold
to
Buy
upgrade
$30
AI Analysis
2026-06-03
Reason
Jefferies
Brian Tanquilut
Price Target
$30
AI Analysis
2026-06-03
upgrade
Hold
to
Buy
Reason
Jefferies analyst Brian Tanquilut upgraded Acadia Healthcare to Buy from Hold with a price target of $30, up from $24.50.
Jefferies
Hold
to
Buy
upgrade
$30
2026-06-03
Reason
Jefferies
Price Target
$30
2026-06-03
upgrade
Hold
to
Buy
Reason
As previously reported, Jefferies upgraded Acadia Healthcare to Buy from Hold with a price target of $30, up from $24.50, citing a belief that new management is well-positioned to bring enhanced operational stability, earnings visibility and "a much-needed boost to underperforming assets." The firm's updated bed build analysis points to about 7% upside to Street EBITDA estimates in FY27 and about 14% upside in FY28, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ACHC
Unlock Now

People Also Watch